Recent Updates
Recently added Catalysts
EHTH

eHealth, Inc. Announces Second Quarter 2019 Results Second Quarter 2019 Overview Revenue for the second quarter of 2019 was $65.8 million , a 101% increase compared to $32.7 million for the second quarter of 2018 . GAAP

Key Takeaway: eHealth, Inc. Announces Second Quarter 2019 Results Second Quarter 2019 Overview SANTA CLARA, California-July 25, 2019-eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today its financial results for the second quarter ended June 30, 2

Full Press Release Details

eHealth, Inc. Announces Second Quarter 2019 Results
Second Quarter 2019 Overview
SANTA CLARA, California-July 25, 2019-eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today its financial results for the second quarter ended June 30, 2019.
Scott Flanders, chief executive officer of eHealth stated, "We delivered another strong quarter once again exceeding our expectations and building momentum in our Medicare business that has continued to scale rapidly accompanied by EBITDA margin expansion. Approved Medicare members grew 78% year-over-year, driving a 105% increase in Medicare revenue year-over-year and a significant increase in Medicare segment profit. Based on our performance to-date, access to expanded telesales capacity and continued progress in gaining greater effectiveness across our operations, we are increasing our 2019 revenue and Adjusted EBITDA guidance for the second time this year."
GAAP-Second Quarter of 2019 Results
Revenue-Revenue for the second quarter of 2019 totaled $65.8 million, a 101% increase compared to $32.7 million for the second quarter of 2018. Commission revenue for the second quarter of 2019 totaled $60.6 million, a 98% increase compared to $30.6 million for the second quarter of 2018. Other revenue for the second quarter of 2019 was $5.2 million, a 157% increase compared to $2.0 million for the second quarter of 2018.
Revenue from our Medicare segment was $52.3 million for the second quarter of 2019, a 105% increase compared to $25.5 million for the second quarter of 2018. Revenue from our Individual, Family and Small Business segment was $13.5 million for the second quarter of 2019, an 88% increase compared to $7.2 million for the second quarter of 2018.
Loss from Operations-Loss from operations for the second quarter of 2019 was $12.3 million compared to loss from operations of $16.9 million for the second quarter of 2018. Operating margin was (18.7)% for the second quarter of 2019 compared to (51.8)% for the second quarter of 2018.
Pre-tax Loss-Pre-tax loss for the second quarter of 2019 was $11.6 million compared to pre-tax loss of $16.6 million for the second quarter of 2018.
Benefit from Income Taxes-Benefit from income taxes for the second quarter of 2019 was $5.9 million compared to benefit from income taxes of $4.6 million for the second quarter of 2018.
Net Loss-Net loss for the second quarter of 2019 was $5.8 million, or $0.25 net loss per diluted share, compared to net loss of $12.0 million, or $0.63 net loss per diluted share, for the second quarter of 2018. Net loss for the second quarter of 2019 included a non-cash charge of $7.2 million related to an increase in fair value of the earnout liability assumed in connection with eHealth's acquisition of GoMedigap. The increase was driven primarily by eHealth's share price appreciation. The share price appreciation has increased the value of the equity-based portion of the earnout consideration owed to the former holders of GoMedigap equity interests.
Segment Profit (Loss)-Profit from our Medicare segment was $6.1 million for the second quarter of 2019, compared to a loss of $1.5 million for the second quarter of 2018. Profit from our Individual, Family and Small Business segment was $5.3 million for the second quarter of 2019, compared to a loss of $0.6 million for the second quarter of 2018.
Non-GAAP-Second Quarter of 2019 Results
Non-GAAP Operating Income (Loss) & Non-GAAP Net Income (Loss)-Non-GAAP operating income for the second quarter of 2019 was $0.1 million compared to non-GAAP operating loss of $10.7 million for the second quarter of 2018. Non-GAAP operating margin was 0.2% for the second quarter of 2019, compared to (32.8)% for the second quarter of 2018. Non-GAAP net income for the second quarter of 2019 was $2.3 million, or $0.10 non-GAAP net income per diluted share, compared to non-GAAP net loss of $7.5 million, or $0.40 non-GAAP net loss per diluted share, for the second quarter of 2018.
Non-GAAP operating income and non-GAAP operating margin for the second quarter of 2019 are calculated by excluding $4.7 million of stock-based compensation expense, $7.2 million of expense for the change in fair value of earnout liability related to our acquisition of GoMedigap, and $0.5 million of amortization of intangible assets from GAAP net operating loss and GAAP operating margin. Non-GAAP net income and non-GAAP net income per diluted share for the second quarter of 2019 are calculated by excluding $4.7 million of stock-based compensation expense, $7.2 million of expense for the change in fair value of earnout liability related to our acquisition of GoMedigap, $0.5 million of amortization of intangible assets and $4.4 million of the income tax effect of these non-GAAP adjustments from GAAP net loss and GAAP net loss per diluted share. Non-GAAP operating loss and non-GAAP operating margin for the second quarter of 2018 are calculated by excluding $3.1 million of stock-based compensation expense, $2.5 million expense for change in fair value of earnout liability related to our acquisition of GoMedigap, and $0.5 million of amortization of intangible assets from GAAP net operating loss and GAAP operating margin. Non-GAAP net loss and non-GAAP net loss per diluted share for the second quarter of 2018 are calculated by excluding $3.1 million of stock-based compensation expense, $2.5 million expense for change in fair value of earnout liability related to our acquisition of GoMedigap, $0.5 million of amortization of intangible assets, and $1.7 million of the income tax effect of these non-GAAP adjustments from GAAP net loss and GAAP net loss per diluted share.
Adjusted EBITDA-Adjusted EBITDA was $0.8 million for the second quarter of 2019 compared to $(10.1) million for the second quarter of 2018. Adjusted EBITDA is calculated by adding stock-based compensation, change in fair value of earnout liability related to our acquisition of GoMedigap, depreciation and amortization expense, acquisition costs, restructuring charges, amortization of intangible assets, other income, net and benefit from income taxes to GAAP net loss.
Submitted Applications, Approved Members and Estimated Membership
Submitted Applications-The number of submitted applications for all Medicare products, which includes Medicare Advantage, Medicare Supplement and Medicare Part D Prescription Drug Plans, was 56,488 in the second quarter of 2019, a 67% increase compared to 33,756 in the second quarter of 2018. The percentage of applications for Medicare Advantage and Medicare Supplement products submitted online through our platform increased from 9% for the second quarter of 2018 to 11% for the second quarter of 2019. The number of submitted applications for major medical Individual and Family plan products increased by 82% in the second quarter of 2019 to 4,271 compared to 2,346 in the second quarter of 2018.
Approved Members-The number of approved members for all Medicare products, which includes Medicare Advantage, Medicare Supplement and Medicare Part D Prescription Drug Plans, was 52,569 in the second quarter of 2019, a 78% increase compared to 29,502 in the second quarter of 2018. The number of approved members for major medical individual and family plan products increased by 15% in the second quarter of 2019 to 2,854 compared to 2,489 in the second quarter of 2018.
Estimated Membership-Total estimated membership as of June 30, 2019 was 967,697, a 10% increase compared to the 877,716 estimated members we reported as of June 30, 2018. Estimated Medicare membership as of June 30, 2019 was 521,262, a 32% increase compared to the 393,937 estimated members we reported as of June 30, 2018. Estimated major medical individual and family plan membership as of June 30, 2019 was 133,543, a 21% decrease compared to the 168,278 estimated members we reported as of June 30, 2018.
Cash-Second Quarter of 2019
Cash Flows-Net cash used in operating activities was $11.5 million for the second quarter of 2019 compared to net cash used in operating activities of $0.3 million for the second quarter of 2018.
GAAP-Year-to-Date Results
Revenue-Revenue for the six months ended June 30, 2019 totaled $134.5 million, a 78% increase compared to $75.7 million for the six months ended June 30, 2018. Commission revenue for the six months ended June 30, 2019 totaled $124.8 million, a 75% increase compared to $71.4 million for the six months ended June 30, 2018. Other revenue for the second quarter of 2019 was $9.7 million, a 122% increase compared to $4.4 million for the six months ended June 30, 2018.
Revenue from our Medicare segment was $107.2 million for the six months ended June 30, 2019, a 91% increase compared to $56.2 million for the six months ended June 30, 2018. Revenue from our Individual, Family and Small Business segment was $27.4 million for the six months ended June 30, 2019, a 40% increase compared to $19.5 million for the six months ended June 30, 2018.
Loss from Operations-Loss from operations for the six months ended June 30, 2019 was $21.5 million compared to loss from operations of $23.6 million for the six months ended June 30, 2018. Operating margin was (16.0)% for the second quarter of 2019 compared to (31.2)% for the six months ended June 30, 2018.
Pre-tax Loss-Pre-tax loss for the six months ended June 30, 2019 was $20.2 million compared to pre-tax loss of $23.2 million for the six months ended June 30, 2018.
Benefit from Income Taxes-Benefit from income taxes for the six months ended June 30, 2019 was $9.3 million compared to benefit from income taxes of $6.3 million for the six months ended June 30, 2018.
Net Loss-Net loss for the six months ended June 30, 2019 was $10.9 million, or $0.48 net loss per diluted share, compared to net loss of $16.9 million, or $0.89 net loss per diluted share, for the six months ended June 30, 2018. Net loss for the six months ended June 30, 2019 included a non-cash charge of $20.5 million related to an increase in fair value of the earnout liability assumed in connection with eHealth's acquisition of GoMedigap. The increase was driven primarily by eHealth's share price appreciation. The share price appreciation has increased the value of the equity-based portion of the earnout consideration owed to the former holders of GoMedigap equity interests.
Segment Profit-Profit from our Medicare segment was $16.9 million for the six months ended June 30, 2019, an 891% increase compared to profit of $1.7 million for the six months ended June 30, 2018. Profit from our Individual, Family and Small Business segment was $11.3 million for the six months ended June 30, 2019, a 293% increase compared to profit of $2.9 million for the six months ended June 30, 2018.
Non-GAAP-Year-to-Date Results
Non-GAAP Operating Income (Loss) & Non-GAAP Net Income (Loss)-Non-GAAP operating income for the six months ended June 30, 2019 was $8.0 million compared to non-GAAP operating loss of $12.5 million for the six months ended June 30, 2018. Non-GAAP operating margin was 6.0% for the six months ended June 30, 2019, compared to (16.5)% for the six months ended June 30, 2018. Non-GAAP net income for the six months ended June 30, 2019 was $9.5 million, or $0.42 non-GAAP net income per diluted share, compared to non-GAAP net loss of $8.9 million, or $0.47 non-GAAP net loss per diluted share, for the six months ended June 30, 2018.
Non-GAAP operating income and non-GAAP operating margin for the six months ended June 30, 2019 are calculated by excluding $7.9 million of stock-based compensation expense, $20.5 million of expense for the change in fair value of earnout liability related to our acquisition of GoMedigap, and $1.1 million of amortization of intangible assets from GAAP operating income and GAAP operating margin. Non-GAAP net income and non-GAAP net income per diluted share for the six months ended June 30, 2019 are calculated by excluding $7.9 million of stock-based compensation expense, $20.5 million of expense for the change in fair value of earnout liability related to our acquisition of GoMedigap, $1.1 million of amortization of intangible assets and $9.1 million of the income tax effect of these non-GAAP adjustments from GAAP net loss and GAAP net loss per share. Non-GAAP operating loss and non-GAAP operating margin for the six months ended June 30, 2018 are calculated by excluding $5.7 million of stock-based compensation expense, $2.5 million change in fair value of earnout liability, $1.9 million of restructuring charges, $1.0 million of amortization of intangible assets and $0.1 million of acquisition costs related to our acquisition of GoMedigap from GAAP net operating loss and GAAP operating margin. Non-GAAP net loss and non-GAAP net loss per diluted share for the six months ended June 30, 2018 are calculated by excluding $5.7 million of stock-based compensation expense, $2.5 million change in fair value of earnout liability, $1.9 million of restructuring charges, $1.0 million of amortization of intangible assets, $0.1 million of acquisition costs related to our acquisition of GoMedigap, and $3.1 million of the income tax effect of these non-GAAP adjustments from GAAP net loss and GAAP net loss per diluted share.
Adjusted EBITDA-Adjusted EBITDA was $9.4 million for the six months ended June 30, 2019 compared to $(11.3) million for the six months ended June 30, 2018. Adjusted EBITDA is calculated by adding stock-based compensation, change in fair value of earnout liability related to our acquisition of GoMedigap, depreciation and amortization expense, acquisition costs, restructuring charges, amortization of intangible assets, other income, net and benefit from income taxes to GAAP net loss.
Submitted Applications and Approved Members
Submitted Applications-The number of submitted applications for all Medicare products, which includes Medicare Advantage, Medicare Supplement and Medicare Part D Prescription Drug Plans was 120,334 applications in the six months ended June 30, 2019, a 75% increase compared to 68,785 in the six months ended June 30, 2018. The percentage of applications for Medicare Advantage and Medicare Supplement products submitted online through our platform increased from 8% for the six months ended June 30, 2018 to 12% for the six months ended June 30, 2019. The number of submitted applications for major medical individual and family plan products decreased by 16% in the six months ended June 30, 2019 to 7,498 compared to 8,916 in the six months ended June 30, 2018.
Approved Members-The number of approved members for all Medicare products, which includes Medicare Advantage, Medicare Supplement and Medicare Part D Prescription Drug Plans, was 110,468 in the six months ended June 30, 2019, a 73% increase compared to 63,840 in the six months ended June 30, 2018. The number of approved members for major medical individual and family plan products decreased by 45% in the second quarter of 2019 to 14,452 compared to 26,388 in the six months ended June 30, 2018.
Cash-Year-to-Date Results
Cash Flows-Net cash provided by operating activities was $1.2 million for the six months ended June 30, 2019 compared to net cash provided by operating activities of $10.4 million for the six months ended June 30, 2018.
eHealth is revising its guidance for the full year ending December 31, 2019 based on information available as of July 25, 2019. These expectations are forward-looking statements and eHealth assumes no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth's annual and quarterly filings with the Securities and Exchange Commission.
The following guidance is for the full year ending December 31, 2019:
(a) Non-GAAP net income per diluted share is calculated by adding stock-based compensation expense per diluted share, change in fair value of earnout liability per diluted share, intangible asset amortization expense per diluted share and the income tax effect of these non-GAAP adjustments to GAAP net income per diluted share.
(b) Adjusted EBITDA is calculated by adding stock-based compensation, change in fair value of earnout liability, depreciation and amortization expense, amortization of intangible assets, other income, net and provision for income taxes to GAAP net income.
(c) Segment profit is calculated as revenue for the applicable segment less Marketing and Advertising, Customer Care and Enrollment, Technology and Content and General and Administrative operating expenses, excluding stock-based compensation, change in fair value of earnout liability, depreciation and amortization expense and amortization of intangible assets, that are directly attributable to the applicable segment and other indirect Marketing and Advertising, Customer Care and Enrollment and Technology and Content operating expenses, excluding stock-based compensation, depreciation and amortization expense and amortization of intangible assets, allocated to the applicable segment based on usage.
(d) Corporate consists of other indirect General and Administrative operating expenses, excluding stock-based compensation and depreciation and amortization expense, which are managed in a corporate shared services environment and, since they are not the responsibility of segment operating management, are not allocated to the reportable segments.
Webcast and Conference Call Information
A Webcast and conference call will be held today, Thursday, July 25, 2019 at 5:00 p.m. Eastern / 2:00 p.m. Pacific Time. The Webcast will be available live on the Investor Relations section on eHealth's website at http://ir.ehealthinsurance.com. Individuals interested in listening to the conference call may do so by dialing (877) 930-8066 for domestic callers and (253) 336-8042 for international callers. The participant passcode is 6597788. A telephone replay will be available two hours following the conclusion of the call for a period of seven days and can be accessed by dialing (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. The call ID for the replay is 6597788. The live and archived webcast of the call will also be available on eHealth's website at http://www.ehealthinsurance.com under the Investor Relations section.
eHealth, Inc. (NASDAQ: EHTH) operates eHealth.com, a leading private online health insurance exchange where individuals, families and small businesses can compare health insurance products from leading insurers side by side and purchase and enroll in coverage online. eHealth offers thousands of individual, family and small business health plans underwritten by many of the nation's leading health insurance companies. eHealth (through its subsidiaries) is licensed to sell health insurance in all 50 states and the District of Columbia. eHealth also offers educational resources and powerful online and pharmacy-based tools to help Medicare beneficiaries navigate Medicare health insurance options, choose the right plan and enroll in select plans online through PlanPrescriber.com (www.PlanPrescriber.com), eHealthMedicare.com (www.eHealthMedicare.com), Medicare.com (www.Medicare.com) and GoMedigap.com (www.GoMedigap.com).
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding our expected growth in 2019, our ability to scale our Medicare business, our expanded telesales capacity, the effectiveness of our operations, our estimates regarding total membership, Medicare membership, Individual and Family plan membership and ancillary and small business membership, our estimates regarding constrained lifetime values of commissions per member and constraints on lifetime value by product category, and our revised guidance for the full year ending December 31, 2019, including our guidance for total revenue and revenue from our Medicare segment and our Individual, Family and Small Business segment, GAAP net income per diluted share and Non-GAAP net income per diluted share, GAAP net income, Adjusted EBITDA, profit from our Medicare segment and our Individual, Family and Small Business segment, Corporate shared service expense, cash used in operations and cash used for capital expenditures.
These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. In particular, we are required by the revenue recognition standard to make numerous assumptions that are based on historical trends and our management's judgment. These assumptions may change over time and have a material impact on our revenue recognition, guidance, and results of operations. Please review the assumptions stated in this press release carefully.
The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include our ability to retain existing members and enroll new members during the annual healthcare open enrollment period and Medicare annual enrollment period; the impact of the annual enrollment period on the purchase of individual and family health insurance and its timing on our recognition of revenue; changes in laws and regulations, including in connection with healthcare reform or with respect to the marketing and sale of Medicare plans; the success of our sale of short-term health insurance; our ability to comply with CMS guidance and the impact on conversion rates from federal exchange changes to enrollment; competition, including competition from government-run health insurance exchanges; the seasonality of our business and the fluctuation of our operating results; changes in consumer behaviors and their selection of individual and family health insurance products, including the selection of products for which we receive lower commissions; changes in product offerings among carriers on our ecommerce platform and the resulting impact on our commission revenue; carriers exiting the market of selling individual and family health insurance and the resulting impact on our supply and commission revenue; our ability to execute on our growth strategy in the Medicare and small business health insurance markets; exposure to security risks and our ability to safeguard the security and privacy of confidential data; the impact of increased health insurance costs on demand; our ability to timely receive and accurately predict the amount of commission payments from health insurance carriers; medical loss ratio requirements; our ability to accurately estimate membership and lifetime value of commissions; our relationships with health insurance carriers; customer concentration and consolidation of the health insurance industry; our success in marketing and selling health insurance plans and our unit cost of acquisition; our ability to hire, train and retain licensed health insurance agents and other employees; the need for health insurance carrier and regulatory approvals in connection with the marketing of Medicare-related insurance products; costs of acquiring new members; scalability of the Medicare business; consumer satisfaction of our service; changes in member conversion rates and our ability to attract and convert online visitors into paying members; changes in commission rates; our ability to sell qualified health insurance plans to subsidy-eligible individuals and to enroll subsidy-eligible individuals through government-run health insurance exchanges; our ability to maintain and enhance our brand identity; our ability to derive desired benefits from investments in our business, including membership growth initiatives; reliance on marketing partners; the impact of our direct-to-consumer email, telephone and television marketing efforts; timing of receipt and accuracy of commission reports; payment practices of health insurance carriers; our ability to successfully make and integrate acquisitions; dependence on our operations in China; the restrictions in our debt obligations; compliance with insurance and other laws and regulations; and the performance, reliability and availability of our ecommerce platform and underlying network infrastructure. Other factors that could cause operating, financial and other results to differ are described in eHealth's most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the investor relations page of eHealth's website at http://www.ehealthinsurance.com and on the Securities and Exchange Commission's website at www.sec.gov.
All forward-looking statements in this press release are based on information available to eHealth as of the date hereof, and eHealth does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.
Non-GAAP Financial Information
This press release includes financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). To supplement eHealth's condensed consolidated financial statements presented in accordance with GAAP, eHealth presents investors with certain non-GAAP financial measures, including non-GAAP operating income (loss); non-GAAP operating margins; non-GAAP net income (loss); non-GAAP net income (loss) per diluted share; and adjusted EBITDA.
eHealth believes that the presentation of these non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to eHealth's financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provides consistency and comparability with eHealth's past financial reports. Management also believes that the items described above provides an additional measure of eHealth's operating results and facilitates comparisons of eHealth's core operating performance against prior periods and business model objectives. This information is provided to investors in order to facilitate additional analyses of past, present and future operating performance and as a supplemental means to evaluate eHealth's ongoing operations. eHealth believes that these non-GAAP financial measures are useful to investors in their assessment of eHealth's operating performance.
Non-GAAP operating income (loss), non-GAAP operating margins, non-GAAP net income (loss), non-GAAP net income (loss) per diluted share and Adjusted EBITDA are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures used in this press release have limitations in that they do not reflect all of the revenue and costs associated with the operations of eHealth's business and do not reflect income tax as determined in accordance with GAAP. As a result, you should not consider these measures in isolation or as a substitute for analysis of eHealth's results as reported under GAAP. eHealth expects to continue to incur the stock-based compensation costs and purchased intangible asset amortization costs described above, and exclusion of these costs, and their related income tax benefits, from non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent. eHealth compensates for these limitations by prominently disclosing GAAP operating income (loss), GAAP operating margins, GAAP net income (loss) and GAAP net income (loss) per diluted share and providing investors with reconciliations from eHealth's GAAP operating results to the non-GAAP financial measures for the relevant periods.
The accompanying tables provide more details on the GAAP financial measures that are most directly comparable to the non-GAAP financial measures described above and the related reconciliations between these financial measures.
Investor Relations Contact
Kate Sidorovich, CFA
Vice President, Investor Relations
2625 Augustine Drive, Second Floor
Santa Clara, CA, 95054
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
June 30, 2019 December 31, 2018
Assets
Current assets:
Cash and cash equivalents $ 115,883 $ 13,089
Accounts receivable 1,059 3,601
Commissions receivable-current 117,573 134,190
Prepaid expenses and other current assets 12,180 5,288
Total current assets 246,695 156,168
Commissions receivable-non-current 223,842 211,668
Property and equipment, net 9,708 7,684
Operating lease right-of-use assets 37,744 -
Other assets 14,116 11,276
Intangible assets, net 11,156 12,249
Goodwill 40,233 40,233
Total assets $ 583,494 $ 439,278
Liabilities and stockholders' equity
Current liabilities:
Accounts payable $ 5,523 $ 5,688
Accrued compensation and benefits 15,265 20,763
Accrued marketing expenses 3,671 11,013
Earnout liability-current 33,700 20,730
Lease liabilities-current 3,896 -
Other current liabilities 2,400 2,425
Total current liabilities 64,455 60,619
Debt - 5,000
Earnout liability-non-current - 19,270
Deferred income taxes-non-current 38,366 47,901
Lease liabilities-non-current 35,386 -
Other non-current liabilities 2,022 3,339
Stockholders' equity:
Common stock 34 31
Additional paid-in capital 449,046 298,024
Treasury stock, at cost (199,998 ) (199,998 )
Retained earnings 194,052 204,965
Accumulated other comprehensive income 131 127
Total stockholders' equity 443,265 303,149
Total liabilities and stockholders' equity $ 583,494 $ 439,278
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts, unaudited)
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 2019 2018
Revenue
Commission $ 60,606 $ 30,646 $ 124,833 $ 71,353
Other 5,161 2,011 9,707 4,374
Total revenue 65,767 32,657 134,540 75,727
Operating costs and expenses:
Cost of revenue 449 151 372 303
Marketing and advertising 23,104 14,606 47,045 29,608
Customer care and enrollment 21,479 13,219 41,423 26,458
Technology and content 10,437 7,287 19,454 15,628
General and administrative 14,862 11,240 26,140 21,931
Acquisition costs - 18 - 76
Change in fair value of earnout liability 7,200 2,500 20,506 2,500
Restructuring charges - 9 - 1,865
Amortization of intangible assets 547 547 1,094 998
Total operating costs and expenses 78,078 49,577 156,034 99,367
Loss from operations (12,311 ) (16,920 ) (21,494 ) (23,640 )
Other income, net 699 296 1,256 480
Loss before benefit from income taxes (11,612 ) (16,624 ) (20,238 ) (23,160 )
Benefit from income taxes (5,858 ) (4,610 ) (9,325 ) (6,301 )
Net loss $ (5,754 ) $ (12,014 ) $ (10,913 ) $ (16,859 )
Net loss per share:
Basic and diluted $ (0.25 ) $ (0.63 ) $ (0.48 ) $ (0.89 )
Weighted-average number of shares used in per share amounts:
Basic and diluted 23,091 19,063 22,508 18,968
(1) Includes stock-based compensation as follows:
Marketing and advertising $ 711 $ 553 $ 1,340 $ 923
Customer care and enrollment 285 206 558 371
Technology and content 668 383 1,217 726
General and administrative 3,014 1,989 4,792 3,661
Restructuring charges - - - 251
Total stock-based compensation expense $ 4,678 $ 3,131 $ 7,907 $ 5,932
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 2019 2018
Operating activities
Net loss $ (5,754 ) $ (12,014 ) $ (10,913 ) $ (16,859 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Deferred income taxes (5,992 ) (4,746 ) (9,535 ) (6,482 )
Depreciation and amortization 733 631 1,388 1,250
Amortization of internally developed software 794 534 1,513 1,011
Amortization of intangible assets 547 547 1,094 998
Stock-based compensation expense 4,678 3,131 7,907 5,932
Change in fair value of earnout liability 7,200 2,500 20,506 2,500
Change in deferred rent - (65 ) (1,272 ) 314
Other non-cash items 146 52 224 62
Changes in operating assets and liabilities:
Accounts receivable 2,322 (178 ) 2,543 629
Commissions receivable (13,205 ) 5,086 4,443 27,495
Prepaid expenses and other assets (3,807 ) 673 (2,696 ) (1,120 )
Accounts payable 915 (635 ) 147 (1,202 )
Accrued compensation and benefits 3,892 3,314 (5,498 ) (3,598 )
Accrued marketing expenses (195 ) (60 ) (7,342 ) (1,951 )
Deferred revenue (3,015 ) 665 (118 ) 376
Accrued expense and other liabilities (783 ) 264 (1,166 ) 1,081
Net cash (used in) provided by operating activities (11,524 ) (301 ) 1,225 10,436
Investing activities
Capitalized internal-use software and website development costs (1,946 ) (1,774 ) (3,433 ) (2,763 )
Purchases of property and equipment and other assets (2,277 ) (905 ) (3,786 ) (1,122 )
Payments for security deposits (896 ) - (896 ) -
Acquisition of business, net of cash acquired - - - (14,929 )
Net cash used in investing activities (5,119 ) (2,679 ) (8,115 ) (18,814 )
Financing activities
Proceeds from issuance of common stock, net of issuance costs - - 126,051 -
Net proceeds from exercise of common stock options 888 559 3,255 668
Cash used to net-share settle equity awards (2,172 ) (1,456 ) (3,452 ) (1,742 )
Repayment of debt - - (5,000 ) -
Acquisition-related contingent payments - - (9,542 ) -
Principal payments in connection with finance leases (25 ) (26 ) (50 ) (52 )
Net cash (used in) provided by financing activities (1,309 ) (923 ) 111,262 (1,126 )
Effect of exchange rate changes on cash, cash equivalents and restricted cash (33 ) (65 ) 29 (15 )
Net (decrease) increase in cash, cash equivalents and restricted cash (17,985 ) (3,968 ) 104,401 (9,519 )
Cash, cash equivalents and restricted cash at beginning of period 135,475 34,742 13,089 40,293
Cash, cash equivalents and restricted cash at end of period (1) $ 117,490 $ 30,774 $ 117,490 $ 30,774
(1) The ending balance of cash, cash equivalents and restricted cash as of June 30, 2019 includes $1.6 million of restricted cash, which is classified as part of Prepaid expenses and other current assets on the balance sheet as of June 30, 2019.
(In thousands, unaudited)
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Percent Change 2019 2018 Percent Change
Revenue
Medicare (1) $ 52,267 $ 25,468 105 % $ 107,168 $ 56,231 91 %
Individual, Family and Small Business (2) 13,500 7,189 88 % 27,372 19,496 40 %
Total revenue $ 65,767 $ 32,657 101 % $ 134,540 $ 75,727 78 %
Segment profit (loss)
Medicare segment profit (loss) (3) $ 6,095 $ (1,473 ) 514 % $ 16,921 $ 1,707 891 %
Individual, Family and Small Business segment profit (loss) (3) 5,268 (617 ) 954 % 11,292 2,871 293 %
Total segment profit (loss) 11,363 (2,090 ) 644 % 28,213 4,578 516 %
Corporate (4) (10,516 ) (7,994 ) 32 % (18,812 ) (15,848 ) 19 %
Stock-based compensation expense (4,678 ) (3,131 ) 49 % (7,907 ) (5,681 ) 39 %
Depreciation and amortization (733 ) (631 ) 16 % (1,388 ) (1,250 ) 11 %
Acquisition costs - (18 ) (100 )% - (76 ) (100 )%
Change in fair value of earnout liability (7,200 ) (2,500 ) 188 % (20,506 ) (2,500 ) 720 %
Restructuring charges - (9 ) (100 )% - (1,865 ) (100 )%
Amortization of intangible assets (547 ) (547 ) - % (1,094 ) (998 ) 10 %
Other income, net 699 296 136 % 1,256 480 162 %
Loss before benefit from income taxes $ (11,612 ) $ (16,624 ) (30 )% $ (20,238 ) $ (23,160 ) (13 )%
We evaluate our business performance and manage our operations as two distinct reporting segments:
(1) The Medicare segment consists primarily of amounts earned from our sale of Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, and to a lesser extent, ancillary products sold to our Medicare-eligible customers, including but not limited to, dental and vision, our advertising program that allows Medicare-related carriers to purchase advertising on a separate website developed, hosted and maintained by us, and our delivery and sale to third parties of Medicare-related health insurance leads generated by our ecommerce platforms and our marketing activities.
(2) The Individual, Family and Small Business segment consists primarily of amounts earned from our sale of individual, family and small business health insurance plans and ancillary products sold to our non-Medicare-eligible customers, including but not limited to dental, vision, and short-term insurance. To a lesser extent, the Individual, Family and Small Business segment consists of amounts earned from our online sponsorship program that allows carriers to purchase advertising space in specific markets in a sponsorship area on our website, our licensing to third parties the use of our health insurance ecommerce technology, and our delivery and sale to third parties of individual and family health insurance leads generated by our ecommerce platforms and our marketing activities.
(3) Segment profit (loss) is calculated as revenue for the applicable segment less Marketing and Advertising, Customer Care and Enrollment, Technology and Content and General and Administrative operating expenses, excluding stock-based compensation, depreciation and amortization expense, acquisition costs, change in fair value of earnout liability, restructuring charges and amortization of intangible assets, that are directly attributable to the applicable segment and other indirect Marketing and Advertising, Customer Care and Enrollment and Technology and Content operating expenses, excluding stock-based compensation, depreciation and amortization expense and amortization of intangible assets, allocated to the applicable segment based on usage.
(4) Corporate consists of other indirect General and Administrative operating expenses, excluding stock-based compensation, depreciation and amortization expense, which are managed in a corporate shared services environment and, because they are not the responsibility of segment operating management, are not allocated to the reportable segments.
SUMMARY OF SELECTED METRICS
COMMISSION REVENUE BY PRODUCT
(In thousands, unaudited)
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Percent Change 2019 2018 Percent Change
Medicare
Medicare Advantage $ 36,607 $ 17,738 106 % $ 76,450 $ 39,673 93 %
Medicare Supplement 8,256 5,355 54 % 16,853 10,947 54 %
Medicare Part D 1,765 715 147 % 4,101 1,874 119 %
Total Medicare 46,628 23,808 96 % 97,404 52,494 86 %
Individual and Family (1)
Non-Qualified Health Plans 5,817 1,069 444 % 8,446 2,510 236 %
Qualified Health Plans 553 1,675 (67 )% 4,061 3,837 6 %
Total Individual and Family 6,370 2,744 132 % 12,507 6,347 97 %
Ancillaries
Short-term 2,695 1,293 108 % 4,011 2,543 58 %
Dental 928 147 531 % 1,718 1,366 26 %
Vision 295 391 (25 )% 757 731 4 %
Other 723 (118 ) 713 % 1,674 2,653 (37 )%
Total Ancillaries 4,641 1,713 171 % 8,160 7,293 12 %
Small Business 1,998 1,772 13 % 4,638 4,131 12 %
Commission Bonus 969 609 59 % 2,124 1,088 95 %
Total Commission Revenue $ 60,606 $ 30,646 98 % $ 124,833 $ 71,353 75 %
SUMMARY OF SELECTED METRICS
SUBMITTED APPLICATIONS
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Percent Change 2019 2018 Percent Change
Medicare (1)
Medicare Advantage (2) 38,449 23,149 66 % 82,940 47,945 73 %
Medicare Supplement (2) 10,534 6,868 53 % 20,837 13,256 57 %
Medicare Part D 7,505 3,739 101 % 16,557 7,584 118 %
Total Medicare 56,488 33,756 67 % 120,334 68,785 75 %
Individual and Family (3)
Non-Qualified Health Plans 2,840 1,309 117 % 5,212 5,195 - %
Qualified Health Plans 1,431 1,037 38 % 2,286 3,721 (39 )%
Total Individual and Family 4,271 2,346 82 % 7,498 8,916 (16 )%
Ancillaries (4)
Short-term 12,856 25,779 (50 )% 28,465 45,274 (37 )%
Dental 9,200 9,324 (1 )% 20,363 22,317 (9 )%
Vision 4,060 4,209 (4 )% 9,591 9,793 (2 )%
Other 6,528 8,777 (26 )% 12,741 22,118 (42 )%
Total Ancillaries 32,644 48,089 (32 )% 71,160 99,502 (28 )%
Small Business (5) 1,813 1,672 8 % 3,782 3,392 11 %
Total Submitted Applications 95,216 85,863 11 % 202,774 180,595 12 %
Submitted Applications
Applications are counted as submitted when the applicant completes the application and either clicks the submit button on our website or provides verbal authorization to submit the application. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier, such as providing additional information. In addition, an applicant may submit more than one application.
(1) Medicare-related health insurance applications submitted on our website or through our customer care center during the period, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.
(2) The percentage of applications for Medicare Advantage and Medicare Supplement products submitted online through our platform increased from 9% for the three months ended June 30, 2018 to 11% for the three months ended June 30, 2019. The percentage of applications for Medicare Advantage and Medicare Supplement products submitted online through our platform increased from 8% for the six months ended June 30, 2018 to 12% for the six months ended June 30, 2019.
(3) Major medical Individual and Family Plan ("IFP") health insurance applications submitted on our website during the period. An applicant may submit more than one application. We define our IFP offerings as major medical Individual and Family health insurance plans, which does not include Medicare-related, Small Business or Ancillary plans.
(4) Ancillaries consists primarily of Short-term, Dental and Vision insurance plans submitted on our website during the period.
(5) Applications for Small Business health insurance are counted as submitted when the applicant completes the application, the employees complete their applications, the applicant submits the application to us and we submit the application to the carrier.
SUMMARY OF SELECTED METRICS
Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Percent Change 2019 2018 Percent Change
Medicare
Medicare Advantage 36,576 20,818 76 % 77,317 45,438 70 %
Medicare Supplement 8,769 5,267 66 % 17,400 10,683 63 %
Medicare Part D 7,224 3,417 111 % 15,751 7,719 104 %
Total Medicare 52,569 29,502 78 % 110,468 63,840 73 %
Individual and Family
Non-Qualified Health Plans 1,934 1,275 52 % 8,005 10,488 (24 )%
Qualified Health Plans 920 1,214 (24 )% 6,447 15,900 (59 )%
Total Individual and Family 2,854 2,489 15 % 14,452 26,388 (45 )%
Ancillaries
Short-term 14,129 25,964 (46 )% 29,061 46,960 (38 )%
Dental 9,478 9,302 2 % 22,534 23,464 (4 )%
Vision 4,428 4,444 - % 10,843 11,039 (2 )%
Other 6,146 7,485 (18 )% 11,358 16,731 (32 )%
Total Ancillaries 34,181 47,195 (28 )% 73,796 98,194 (25 )%
Small Business 3,245 3,464 (6 )% 7,497 8,758 (14 )%
Total Approved Members 92,849 82,650 12 % 206,213 197,180 5 %
Approved Members represents the number of individuals on submitted applications that were approved by the relevant insurance carrier for the identified product during the relevant period. Approved Members may not pay for their plan and become paying members.
SUMMARY OF SELECTED METRICS
ESTIMATED MEMBERSHIP
As of June 30,
2019 2018 Percent Change
Medicare (1)
Medicare Advantage 291,171 226,048 29 %
Medicare Supplement 80,779 61,316 32 %
Medicare Part D 149,312 106,573 40 %
Total Medicare 521,262 393,937 32 %
Individual and Family (2) 133,543 168,278 (21 )%
Ancillaries (3)
Short-term 21,513 17,008 26 %
Dental 134,044 150,823 (11 )%
Vision 74,157 75,696 (2 )%
Other 37,102 34,964 6 %
Total Ancillaries 266,816 278,491 (4 )%
Small Business (4) 46,076 37,010 24 %
Total Estimated Membership 967,697 877,716 10 %
Estimated Membership
Estimated Membership represents the estimated number of members active as of the date indicated based on the number of members for whom we have received or applied a commission payment during the month of estimation.
(1) For Medicare-related health insurance plans, we take the sum of (i) the number of members for whom we have received or applied a commission payment for a month that is up to two months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy from the same month of the previous year and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation. The estimated number of members active on Medicare-related health insurance as of the date indicated is based on the number of members for whom we have received or applied a commission payment during the month of estimation.
(2) To estimate the number of members on Individual and Family health insurance plans, we take the sum of (i) the number of IFP members for whom we have received or applied a commission payment for a month that is up to six months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number by the percentage of members who do not accept their approved policy from the same month of the previous year for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation. For IFP health insurance plans, a member who purchases and is active on multiple standalone insurance plans will be counted as a member more than once. For example, a member who is active on both an Individual and Family health insurance plan and a standalone dental plan will be counted as two continuing members.
SUMMARY OF SELECTED METRICS
ESTIMATED MEMBERSHIP (Continued)
(3) For Ancillary health insurance plans (such as Short-term, Dental and Vision insurance), we take the sum of (i) the number of members for whom we have received or applied a commission payment for a month that is up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy from the same month of the previous year and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation. The one to three-month period varies by insurance product and is largely dependent upon the timeliness of commission payment and related reporting from the related carriers.
(4) For Small Business health insurance plans, we estimate the number of members using the number of initial members at the time the group is approved, and we update this number for changes in membership if such changes are reported to us by the group or carrier in the period it is reported. However, groups generally notify the carrier directly of policy cancellations and increases or decreases in group size without informing us. Health insurance carriers often do not communicate policy cancellation information or group size changes to us. We often are made aware of policy cancellations and group size changes at the time of annual renewal and update our membership statistics accordingly in the period they are reported.
Health insurance carriers bill and collect insurance premiums paid by our members. The carriers do not report to us the number of members that we have as of a given date. The majority of our members who terminate their policies do so by discontinuing their premium payments to the carrier and do not inform us of the cancellation. Also, some of our members pay their premiums less frequently than monthly. Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on insurance policies as of a specified date.
After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. For instance, we reconcile information carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated membership. Conversely, carriers may require us to return commission payments paid in a prior period due to policy cancellations for members we previously estimated as being active. We do not update our estimated membership numbers reported in previous periods. Instead, we reflect updated information regarding our historical membership in the membership estimate for the current period. As a result of the delay in our receipt of information from insurance carriers, actual trends in our membership are most discernible over periods longer than from one quarter to the next. As a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current conditions on our membership retention. Healthcare reform and its impacts as well as other factors could cause the assumptions and estimates that we make in connection with estimating our membership to be inaccurate, which would cause our membership estimates to be inaccurate.
Last updated: Jul 25, 2019